High-Med.Przychodnia Specjalistyczna
Warsaw 01-817
0 studies enrolling now · 9 studies all time
What they study most
Atopic Dermatitis, Dermatitis, Atopic, Eczema, Glabellar Frown Lines, Prurigo Nodularis, Psoriasis, Psoriasis Vulgaris, Skin Diseases
Studies at this site
- A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
- A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) — Running, not enrolling
- A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
- Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis — Running, not enrolling
- Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I — Completed
- Study to Assess the Efficacy and Safety of Orismilast in Psoriasis — Completed
- A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis — Completed
- An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
- Tofacitinib Ointment For Chronic Plaque Psoriasis — Completed